Related Interviews

Buying Solid Stocks When They Are Undervalued
May 10, 2019
Kahn, Thomas G.

Being More Selective and Focusing on Data in the Gene Therapy Space
April 05, 2019
Amusa, Gbola

Major Pharmas Becoming Increasingly Comfortable with Gene Therapy
March 22, 2019
Zhong, Yun

The First Half of 2019 Expected to Be Rough for the Biotech Sector
March 15, 2019
Singh, Hartaj

CRISPR and NASH Will Be Particularly Interesting and Exciting in 2019
March 15, 2019
Seedhouse, Steven

Building a Portfolio with Multiple Levels of Diversification
January 04, 2019
Cuggino, Michael J.

A Favorable Future for Today’s Leaner, More Data-Driven Biotechs
October 02, 2018
Selvaraju, Raghuram

Data Consistency is Important When Investing in Gene Therapy
March 21, 2018
Chattopadhyay, Debjit

Good Management Teams and Good Science are Creating Opportunities in Biotech
March 08, 2018
Singh, Hartaj

Biotech Space Lining Up for New Product Cycle
April 21, 2017
Singh, Hartaj

Looking for Growth, Consistency and Financial Strength
March 24, 2017
Maronak, Erick

A Cautious Perspective on the Biotechnology Sector
March 10, 2017
Shrader, Thomas

Applying Bottom-Up Fundamental Research in the Large-Cap Space
February 24, 2017
Fitzpatrick, Owen

Assuming a Higher Risk Profile if Tax Rates are Lowered
January 27, 2017
Havens, Peter H.

Investing for the Long Term in Biotechnology
October 21, 2016
Webb, Dallas

Seeking Global Equities with High Returns on Invested Capital
September 23, 2016
Perez Fernandez, Francisco Javier

Outperforming the Market with Less Volatility
September 09, 2016
Abelson, Adam S.

Critical Demand for Innovation in Pharma and Biotech
August 12, 2016
Brozak, Steve

Investing in Disruptive High-Growth Companies
April 08, 2016
Tubbs, Leslie

Supplementing a Growth-Oriented Portfolio with Out-of-Favor Sectors
January 29, 2016
Ray, Joseph H.

Using a Thematic Approach to Growth Investing
October 23, 2015
Kenneth D. Malamed

Finding Opportunities in Consistent Secular-Growth Companies
August 10, 2015

Opportunities in Regenerative Medicine, Cancer Immunotherapy Markets for Value Investors
July 06, 2015

Strong Fundamentals in Biotech Justify Even Higher Valuation Levels
December 11, 2014

Clinical Advancements and Drug Launches in Therapeutics Fuel Investor Enthusiasm
August 19, 2014

Strong Outlook for Orphan and Oncology Treatments
April 03, 2014

Targeted Genetic and Cell Therapies Stand Out in Biotechnology
April 01, 2014

Buying Great Companies and Investing for the Long Term
March 27, 2014

A Health Care Convergence of Biotech, Pharma and Medical Devices 
February 21, 2014

A Diversified Large-Cap Strategy with a Focus in Earnings
November 07, 2013

An Investment Strategy Focused On Capturing Positive Uptrends
October 08, 2013

Increased Biotech Productivity and Innovation Reflected in FDA-Approved Drugs
August 23, 2013

Oncology and Orphan Drugs Retain Pricing Power
August 14, 2013

Investing in Health Care Innovation
April 30, 2013

High Success Rates and Significant M&A in the Antibody Space
April 16, 2013

Opportunities in Hepatitis C and Genomic Technologies
April 08, 2013

Finding Innovation in Biotechnology for Cell Therapy, Oncology and Orphan Drugs
April 05, 2013

Identifying Hidden Value and Market Opportunities in Biotech Companies
March 21, 2013

Utilizing Trends for Stock Selection Over the Longer Term
October 23, 2012

Hepatitis C Therapies Propel Growth in Biotech
August 30, 2012

Emerging-Growth Opportunities in Oncology Biotech
August 29, 2012

U.S. Biotech Valuations Appear Attractive Despite Earlier Run
August 17, 2012

Innovation In Cardiovascular And Hepatic Devices And Drugs - Duane Nash - Wedbush Securities
November 21, 2011

"common Sense" Investment Management - Kendall J. Anderson - Anderson Griggs Portfolio Management
November 14, 2011

Capitalizing On The Secular Increase Of Time Spent Online - Herman Leung - Susquehanna Financial Group Lllp
October 17, 2011

Investing In Small- & Midcap Biotech Companies - Dr. Jason Kantor - Rbc Capital Markets
April 04, 2011

Technology Enablers Monetize Platform Shifts - Kerry Rice - Wedbush Securities
April 04, 2011

Continued M&a Activity In The Specialty Pharma Space - David Amsellem - Piper Jaffray & Co.
November 15, 2010

An Eye On Value & Long-term Growth In Health Services - Dr. Alastair Mackay - Garp Research & Securities
November 15, 2010

Risk Factors & Overheated Insurance Valuations - Peter Newell - Vontobel Asset Management, Inc.
May 17, 2010

A Close Look At Therapeutics Within Biotech - Matthew L. Kaplan - Ladenburg Thalmann & Co.
April 05, 2010

Investing In Commodities & Resources - James J. Puplava - Puplava Financial Services, Inc
November 02, 2009

Roundtable Forum: Midwest Banks
June 15, 2009

Investing In Large Cap Growth Stocks - Chris D. Bowen & Ryan Snow - Wasatch Funds
May 18, 2009

INVESTING IN DIABETES-RELATED STOCKS - DAVID A. KLIFF - DIABETIC INVESTOR
November 17, 2008

EQUITY INVESTMENT STRATEGIES FOR SMAS - ROBERT K. MADDOCK - INVERNESS COUNSEL, INC.
May 19, 2008

INVESTING IN LARGE CAP VALUE STOCKS - BRUCE W. KASER - VOYAGEUR ASSET MANAGEMENT INC.
March 10, 2008

SMALL & MICRO-CAP BIOTECHNOLOGY COMPANIES - GEORGE B. ZAVOICO - CANTOR FITZGERALD
February 25, 2008

INVESTING IN LARGE CAP GLOBAL OPPORTUNITIES - NICK ROBINSON - ABERDEEN ASSET MANAGEMENT
October 22, 2007

Investing In Growth Companies With Peg Ratio Valuation - Stephen Leeb - Leeb Capital Management, Inc.
July 23, 2007

SMALL CAP GROWTH INVESTING - JAMES A. BITZER - EGM CAPITAL, LLC
December 04, 2006

ROUNDTABLE FORUM: BROADCASTING
November 06, 2006

DIGITAL MARKETING TECHNOLOGY PROVIDERS - KYLE EVANS - STEPHENS INC.
November 06, 2006

CHARLES L. NORTON & ALLEN R. GILLESPIE - GNI CAPITAL, INC.
September 11, 2006

PULMONARY ARTERIAL HYPERTENSION: ANDREW FEIN - C.E. UNTERBERG, TOWBIN
July 03, 2006

RICHARD PARRY - TOM JOHNSON INVESTMENT MANAGEMENT
April 17, 2006

DAVID YUCIUS JR. - AURORA INVESTMENT COUNSEL
February 27, 2006

PACKAGED FOODS & AGRIBUSINESS: JOHN MCMILLIN - PRUDENTIAL EQUITY GROUP LLC
February 27, 2006

DENIS TURKO - HAVEN CAPITAL MANAGEMENT LLC
December 05, 2005

L.FRIDAY / P.SWANSON - KING INVESTMENT ADVISORS INC
November 14, 2005

EMERGING GROWTH LIFE SCIENCES COMPANIES: KEAY NAKAE - C.E. UNTERBERG, TOWBIN
October 25, 2005

ROUNDTABLE FORUM: WIRELESS EQUIPMENT
July 18, 2005

K.CRONK / T.LAPOINTE - COLUMBIA MANAGEMENT GROUP
June 27, 2005

ROUNDTABLE FORUM: BIOTECHNOLOGY
June 27, 2005

Oscar Spieler - Frontline Ltd (fro)
March 07, 2005

INVESTING IN SUNBELT COMMUNITY BANKS: J.DEMBA / G.TENNER - SUNTRUST ROBINSON HUMPHREY
September 28, 2004

OUTLOOK FOR PAPER & FOREST PRODUCTS: STEVE CHERCOVER - D.A.DAVIDSON & CO
September 20, 2004

KEVIN CAREY - 1ST SOURCE CORPORATION INVESTMENT ADVISORS INC
July 19, 2004

DEPARTMENT STORES, DISCOUNTERS & DOLLAR STORES: SHARI EBERTS - J.P. MORGAN CHASE
April 05, 2004

Small Cap Biotechnology Companies: Russell Gilbertson - Roth Capital Partners Llc
July 28, 2003

Marine Transport / Tanker Stocks: Jill Evans - J.p. Morgan Chase
April 14, 2003

Thomas Quealy Jr. - Elias Asset Management Inc
March 24, 2003

Robert Van Nostrand - Osi Pharmaceuticals Inc (osip)
September 13, 2002

Gold Stocks: Daniel Mcconvey - Goldman Sachs & Co
May 27, 2002

Ted Love - Hyseq Inc (hysq)
October 12, 2001

Power Technology & Services: Greg Haas - Raymond James & Associates
October 08, 2001

Dana Halberg / Michael Mohr - The Arden Group
September 03, 2001

Mark Frevert - Enron Wholesale Services (ene)
May 31, 2001

Michael Mcallister - Humana Inc (hum)
January 10, 2001

Doug Cahn - Reebok International Ltd (rbk)
December 25, 2000

Roundtable Forum: Investing In Gold Companies
December 25, 2000

E.o. Edgerton Jr. - Capital Investment Counsel Inc
August 14, 2000

Alfred Scheid - Scheid Vineyards Inc (svin)
August 14, 2000

Allen Ashcroft Jr. - Allied Investment Advisors
June 05, 2000

Malinda Berardino - Church Capital Management
March 27, 2000

Eric Miller - Heartland Advisors
December 20, 1999

Joseph J. Corasanti - Conmed Corporation (cnmd)
September 30, 1999

Vaughn M. Kailian - Cor Therapeutics Inc (corr)
December 14, 1998